Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 8, 2005, Pages 2049-2052

  Frattini, Milo ^a   Carnevali, Ileana ^a   Signoroni, Stefano ^a   Balestra, Debora ^a   Moiraghi, Maria Luisa ^a   Radice, Paolo ^a   Varesco, Liliana ^b   Gismondi, Viviana ^b   Ballardini, Giovanni ^a   Sala, Paola ^a   Pierotti, Marco A ^a   Pilotti, Silvana ^a   Bertario, Lucio ^a,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b Istituto Nazionale Tumori   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; AUTOSOMAL DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FAMILIAL COLON POLYPOSIS; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GERM LINE; GERM LINE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYH GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; DNA GLYCOSYLASES; FEMALE; GERM-LINE MUTATION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 23844497338     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0028     Document Type: Article

References (19)

1. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001;10:721-3.
2. Al-Tassan AN, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 2002;30:227-32.
3. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.
4. Gismondi V, Meta M, Bonelli L, et al. Prevalence of Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004;109:680-4.
5. Cheadle JP, Sampson JR. Exposing the MYtH about base excision repair and human inherited disease. Hum Mol Genet 2003;12:R159-65.
6. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 2002;11:2961-7.
7. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
8. Grover JK, Yadav S, Vats V, Joshi YK. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut. Int J Colorectal Dis 2003;18:279-91.
9. Steinbach G, Lynch PM, Phillips RKS, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
10. Hallak A, Alon-Baron L, Shamir R, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 2003;48:1998-2002.
11. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18:7908-16.
12. Takafuji V, Lublin D, Lynch K, Roche JK. Mucosal prostanoids receptors and synthesis in familial adenomatous polyposis. Histochem Cell Biol 2001;116:171-81.
13. Giarola M, Stagi L, Presciuttini S, et al. Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 1999;13:116-23.
14. Frattini M, Balestra D, Suardi S, et al. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004;10:4015-21.
15. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992;89:7384-8.
16. Peng JP, Su CY, Chang HC, Chai CY, Hung WC. Overexpression of cyclooxygenase 2 in squamous cell carcinoma of the hypopharynx. Hum Pathol 2002;33:100-4.
17. Hsi LC, Angerman-Stewart J, Eling TE. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 1999;20:2045-9.
18. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
19. Boon EMJ, Keller JJ, Wormhoudt TAM, et al. Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer 2004;90:224-9.